Wiraphol Phimarn, P. Paktipat, Chatmanee Taengthonglang, Kritsanee Saramunee, Bunleu Sungthong
{"title":"A meta-analysis and meta-regression study of the effects of Triphala on anthropometric parameters","authors":"Wiraphol Phimarn, P. Paktipat, Chatmanee Taengthonglang, Kritsanee Saramunee, Bunleu Sungthong","doi":"10.34172/jhp.2022.54","DOIUrl":null,"url":null,"abstract":"Triphala is a medicinal plant that can improve anthropometric parameters. Although Triphala is widely used, especially in India and Thailand, its efficacy is still controversial. Consequently, the purpose of this meta-analysis and meta-regression analysis was to assess the safety of Triphala and its effects on anthropometric parameters. A comprehensive review and meta-analysis of randomized controlled trials assessing the safety of Triphala and its effects on anthropometric parameters were conducted by searching PubMed, ScienceDirect, Web of Science, and ThaiLIS databases. Two authors independently conducted the study selection and data extraction and evaluated the quality of the studies. The clinical therapeutic effects and adverse events of Triphala were evaluated and aggregated using a random-effects model. The chi-square and I2 tests were used to assess heterogeneity between the studies. Seven trials with a total of 458 patients were included. The Triphala-treated groups demonstrated a considerable decrease in body weight (BW) (weighted mean difference [WMD]: −2.99 kg; 95% CI: −5.31, −0.67; P = 0.012; I2 = 94.4%), body mass index (BMI) (WMD: −0.79 kg/m2; 95% CI: −1.52, −0.07; P = 0.032; I2 = 90.4%), and waist circumference (WC) (WMD: −1.86 cm; 95% CI: −3.10, −0.62; P = 0.003; I2 = 88.8%). During the treatment period, there were no reports of serious adverse events related to Triphala. However, there was no association between the dose or duration of treatment and any of the recorded outcomes. This meta-analysis revealed that Triphala significantly improved BW, BMI, and WC. Nevertheless, substantial, well-designed randomized controlled studies are necessary to confirm this finding.","PeriodicalId":15934,"journal":{"name":"Journal of HerbMed Pharmacology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of HerbMed Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/jhp.2022.54","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Triphala is a medicinal plant that can improve anthropometric parameters. Although Triphala is widely used, especially in India and Thailand, its efficacy is still controversial. Consequently, the purpose of this meta-analysis and meta-regression analysis was to assess the safety of Triphala and its effects on anthropometric parameters. A comprehensive review and meta-analysis of randomized controlled trials assessing the safety of Triphala and its effects on anthropometric parameters were conducted by searching PubMed, ScienceDirect, Web of Science, and ThaiLIS databases. Two authors independently conducted the study selection and data extraction and evaluated the quality of the studies. The clinical therapeutic effects and adverse events of Triphala were evaluated and aggregated using a random-effects model. The chi-square and I2 tests were used to assess heterogeneity between the studies. Seven trials with a total of 458 patients were included. The Triphala-treated groups demonstrated a considerable decrease in body weight (BW) (weighted mean difference [WMD]: −2.99 kg; 95% CI: −5.31, −0.67; P = 0.012; I2 = 94.4%), body mass index (BMI) (WMD: −0.79 kg/m2; 95% CI: −1.52, −0.07; P = 0.032; I2 = 90.4%), and waist circumference (WC) (WMD: −1.86 cm; 95% CI: −3.10, −0.62; P = 0.003; I2 = 88.8%). During the treatment period, there were no reports of serious adverse events related to Triphala. However, there was no association between the dose or duration of treatment and any of the recorded outcomes. This meta-analysis revealed that Triphala significantly improved BW, BMI, and WC. Nevertheless, substantial, well-designed randomized controlled studies are necessary to confirm this finding.
期刊介绍:
Journal of Herbmed Pharmacology (J Herbmed Pharmacol) is the intersection between medicinal plants and pharmacology. This international journal publishes manuscripts in the fields of medicinal plants, pharmacology and therapeutic. This journal aims to reach all relevant national and international medical institutions and persons in electronic version free of charge. J Herbmed Pharmacol has pursued this aim through publishing editorials, original research articles, reviews, mini-reviews, commentaries, letters to the editor, hypothesis, case reports, epidemiology and prevention, news and views. In this journal, particular emphasis is given to research, both experimental and clinical, aimed at protection/prevention of diseases. A further aim of this journal is to emphasize and strengthen the link between herbalists and pharmacologists. In addition, J Herbmed Pharmacol welcomes basic biomedical as well as pharmaceutical scientific research applied to clinical pharmacology. Contributions in any of these formats are invited for editorial consideration following peer review by at least two experts in the field.